The European Patent Office published patent EP3487485A2, granted to Kenvue Brands LLC, covering pharmaceutical tablet formulations with discontinuous coated regions. The patent names inventors Sowden, McNally, and Lee and is classified under A61K 9/20, A61K 9/28, A61J 3/00, and A61J 3/10. The designated states cover all EPO member states including Germany, France, UK, Italy, Spain, and others.

This is a patent grant notice that conveys exclusivity rights rather than imposing compliance obligations. Pharmaceutical companies developing tablet formulations should conduct freedom-to-operate analyses to assess potential infringement risks. R&D and legal teams should review the patent claims to determine whether current or planned products fall within the protected discontinuous coating technology.